Direct-Haler A/S is a privately owned drug delivery device company focusing on research & development and out-licensing of world-wide patented device technologies for pulmonary and nasal delivery
Direct-Haler has a flexible outlook on the development of the company's business, and in how their technology can be fully exploited and commercialized. The company are looking for business partnerships both concerning commercialization (route to market) and for accessing complementary technology to the DirectHaler(TM) technologies.
Partnerships
To view this information, you must subscribe to PL Intelligence.
Deals
To view this information, you must subscribe to PL Intelligence.
Senior management
To view this information, you must subscribe to PL Intelligence.
Contact details
To view this information, you must subscribe to PL Intelligence.
Head office
Direct Haler
Symbion Science Park
Fruebjergvej 3
Copenhagen
DK-2100 Denmark
All rights reserved. Terms and Conditions | Contact us
